These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 24040789

  • 1. Highly organized nanostructures for brain drug delivery--new hope or just a fad?
    Labuzek K, Gorki K, Jaroszek H, Jarzabek K, Gabryel B, Okopien B.
    CNS Neurol Disord Drug Targets; 2013 Dec; 12(8):1271-85. PubMed ID: 24040789
    [Abstract] [Full Text] [Related]

  • 2. Modern methods for delivery of drugs across the blood-brain barrier.
    Chen Y, Liu L.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):640-65. PubMed ID: 22154620
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Nanocarriers for oral drug delivery.
    Zhang L, Wang S, Zhang M, Sun J.
    J Drug Target; 2013 Jul 15; 21(6):515-27. PubMed ID: 23621127
    [Abstract] [Full Text] [Related]

  • 8. Concepts, technologies, and practices for drug delivery past the blood-brain barrier to the central nervous system.
    Crawford L, Rosch J, Putnam D.
    J Control Release; 2016 Oct 28; 240():251-266. PubMed ID: 26724368
    [Abstract] [Full Text] [Related]

  • 9. Noninvasive nanoparticle strategies for brain tumor targeting.
    Sun C, Ding Y, Zhou L, Shi D, Sun L, Webster TJ, Shen Y.
    Nanomedicine; 2017 Nov 28; 13(8):2605-2621. PubMed ID: 28756093
    [Abstract] [Full Text] [Related]

  • 10. Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis.
    Nair KGS, Ramaiyan V, Sukumaran SK.
    Inflammopharmacology; 2018 Jun 28; 26(3):675-684. PubMed ID: 29582240
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prodrug approaches to reduce hyperexcitation in the CNS.
    Vytla D, Combs-Bachmann RE, Hussey AM, McCarron ST, McCarthy DS, Chambers JJ.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):666-85. PubMed ID: 22138074
    [Abstract] [Full Text] [Related]

  • 14. Dendritic core-shell systems as soft drug delivery nanocarriers.
    Lukowiak MC, Thota BN, Haag R.
    Biotechnol Adv; 2015 Nov 01; 33(6 Pt 3):1327-41. PubMed ID: 25868804
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The physics of drug-delivery across the blood-brain barrier.
    Guiot C, Zullino S, Priano L, Cavalli R.
    Ther Deliv; 2016 Nov 01; 7(3):153-6. PubMed ID: 26893246
    [No Abstract] [Full Text] [Related]

  • 19. The blood-brain barrier and brain drug delivery.
    Koziara JM, Lockman PR, Allen DD, Mumper RJ.
    J Nanosci Nanotechnol; 2006 Nov 01; 6(9-10):2712-35. PubMed ID: 17048477
    [Abstract] [Full Text] [Related]

  • 20. Nanotechnological advances for the delivery of CNS therapeutics.
    Wong HL, Wu XY, Bendayan R.
    Adv Drug Deliv Rev; 2012 May 15; 64(7):686-700. PubMed ID: 22100125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.